Schepke M - Search Results

1

Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase.

Trebicka J, Hennenberg M, Laleman W, Shelest N, Biecker E, Schepke M, Nevens F, Sauerbruch T, Heller J. Trebicka J, et al. Among authors: schepke m. Hepatology. 2007 Jul;46(1):242-53. doi: 10.1002/hep.21673. Hepatology. 2007. PMID: 17596891

2

[Endoscopy in patients at risk for bleeding].

Schepke M, Unkrig C, Sauerbruch T. Schepke M, et al. Z Gastroenterol. 1997 Feb;35(2):147-53. Z Gastroenterol. 1997. PMID: 9163228 Review. German. No abstract available.

3

Sclerotherapy is out--nearly.

Sauerbruch T, Schepke M. Sauerbruch T, et al. Among authors: schepke m. Endoscopy. 1997 May;29(4):281-2. doi: 10.1055/s-2007-1004190. Endoscopy. 1997. PMID: 9255532 Review. No abstract available.

4

Altered adrenergic responsiveness of endothelium-denuded hepatic arteries and portal veins in patients with cirrhosis.

Heller J, Schepke M, Gehnen N, Molderings GJ, Müller A, Erhard J, Spengler U, Sauerbruch T. Heller J, et al. Among authors: schepke m. Gastroenterology. 1999 Feb;116(2):387-93. doi: 10.1016/s0016-5085(99)70136-8. Gastroenterology. 1999. PMID: 9922320

5

Propranolol stereoisomer plasma concentrations and portal haemodynamic response in patients with liver cirrhosis.

Schepke M, Raab P, Hoppe A, Brensing K, Paar D, Potyka U, Sauerbruch T. Schepke M, et al. Aliment Pharmacol Ther. 1999 Nov;13(11):1451-8. doi: 10.1046/j.1365-2036.1999.00622.x. Aliment Pharmacol Ther. 1999. PMID: 10571601 Free article. Clinical Trial.

6

Comparison of portal vein velocity and the hepatic venous pressure gradient in assessing the acute portal hemodynamic response to propranolol in patients with cirrhosis.

Schepke M, Raab P, Hoppe A, Schiedermaier P, Brensing KA, Sauerbruch T. Schepke M, et al. Am J Gastroenterol. 2000 Oct;95(10):2905-9. doi: 10.1111/j.1572-0241.2000.03202.x. Am J Gastroenterol. 2000. PMID: 11051366

7

Hemodynamic effects of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertension.

Schepke M, Werner E, Biecker E, Schiedermaier P, Heller J, Neef M, Stoffel-Wagner B, Hofer U, Caselmann WH, Sauerbruch T. Schepke M, et al. Gastroenterology. 2001 Aug;121(2):389-95. doi: 10.1053/gast.2001.26295. Gastroenterology. 2001. PMID: 11487548 Clinical Trial.

8

[Liver cirrhosis--case report].

Schepke M, Sauerbruch T. Schepke M, et al. Dtsch Med Wochenschr. 2001 Sep 7;126(36):975. doi: 10.1055/s-2001-16960. Dtsch Med Wochenschr. 2001. PMID: 11544548 German. No abstract available.

9

[Liver cirrhosis--2: Complications and treatment].

Schepke M, Reichel C, Ziske C, Spengler U, Caselmann WH, Sauerbruch T. Schepke M, et al. Dtsch Med Wochenschr. 2001 Sep 7;126(36):978-81; quiz 982-4. doi: 10.1055/s-2001-16962. Dtsch Med Wochenschr. 2001. PMID: 11544550 German. No abstract available.

10

Contractile hyporesponsiveness of hepatic arteries in humans with cirrhosis: evidence for a receptor-specific mechanism.

Schepke M, Heller J, Paschke S, Thomas J, Wolff M, Neef M, Malago M, Molderings GJ, Spengler U, Sauerbruch T. Schepke M, et al. Hepatology. 2001 Nov;34(5):884-8. doi: 10.1053/jhep.2001.28794. Hepatology. 2001. PMID: 11679958

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

69 results

Search Page

Filters